Analysis of cytokines in tear fluid from atopic dermatitis patients with dupilumab-associated ocular adverse events

被引：3
|
作者：
Vuillemey, L. [1 ]
Febvay, C. [1 ]
Puzenat, E. [2 ]
Bellanger, A. P. [3 ]
Chague, C. [4 ]
Puyraveau, M. [5 ]
Delbosc, B. [1 ,4 ]
Gauthier, A. -S. [1 ,4 ]
Aubin, F. [2 ,4 ]
机构：
[1] CHU Besancon, Dept Ophthalmol, Besancon, France
[2] CHU Besancon, Dept Dermatol, Besancon, France
[3] CHU Besancon, Dept Parasitol, Besancon, France
[4] Univ Bourgogne Franche Comte, Federat Hosp Univ INCREASE, Interact Hote Greffon Tumeur Ingn Cellulaire & Ge, LabEx LipSTIC,INSERM,UMR1098,EFS BFC, Besancon, France
[5] CHU Besancon, Dept Clin Res, Besancon, France
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2022年 / 36卷 / 03期
关键词：
VERNAL KERATOCONJUNCTIVITIS; DISEASE;
D O I：
10.1111/jdv.17729
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E195 / E197
页数：3
相关论文
共 50 条
  • [1] Management of dupilumab-associated ocular surface diseases in atopic dermatitis patients
    Guex-Crosier, Yan
    Di-Lucca, Julie
    Hausermann, Peter
    Laffitte, Emmanuel
    Saulite, Ieva
    Schmid-Grendelmeier, Peter
    Schurch, Kaspar
    Thormann, Kathrin
    Simon, Dagmar
    SWISS MEDICAL WEEKLY, 2021, 151
  • [2] Dupilumab-associated ocular adverse events are predicted by low tear break-up time and correlate with high IL-33 tear concentrations in patients with atopic dermatitis
    Chiricozzi, A.
    Di Nardo, L.
    Gori, N.
    Antonelli, F.
    Pinto, L.
    Cuffaro, G.
    Piro, G.
    Savino, G.
    Tortora, G.
    Peris, K.
    EXPERIMENTAL DERMATOLOGY, 2023, 32 (09) : 1531 - 1537
  • [3] Dupilumab-associated cutaneous adverse events among adult patients with atopic dermatitis: A retrospective study
    Napolitano, Maddalena
    Fabbrocini, Gabriella
    Patruno, Cataldo
    JOURNAL OF DERMATOLOGY, 2023, 50 (07): : 880 - 887
  • [4] Dupilumab-Associated Conjunctivitis in Patients With Atopic Dermatitis
    Liberman, Paulina
    Shifera, Amde Selassie
    Berkenstock, Meghan
    CORNEA, 2020, 39 (06) : 784 - 786
  • [5] Dupilumab-associated adverse events
    Reactions Weekly, 2021, 1848 (1) : 6 - 6
  • [6] Dupilumab-associated psoriasis and psoriasiform dermatitis in patients with atopic dermatitis
    Casale, Fiore
    Nguyen, Cristina
    Dobry, Allison
    Smith, Janellen
    Mesinkovska, Natasha Atanaskova
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2022, 63 (03) : 394 - 397
  • [7] Dupilumab-Associated Lymphoid Reactions in Patients With Atopic Dermatitis
    Boesjes, Celeste M.
    van der Gang, Lian F.
    Bakker, Daphne S.
    ten Cate, Tess A.
    Spekhorst, Lotte S.
    de Graaf, Marlies
    van Dijk, Marijke R.
    de Bruin-Weller, Marjolein S.
    JAMA DERMATOLOGY, 2023, 159 (11) : 1240 - 1247
  • [8] Identification of Risk Factors for Dupilumab-associated Ocular Surface Disease in Patients with Atopic Dermatitis
    Achten, Roselie E.
    Van Luijk, Chantal
    Van der Rijst, Lisa
    Bakker, Daphne
    Spekhorst, Lotte
    Zuithoff, Nicolaas
    Schuttelaar, Marie
    Romeijn, Geertruida
    Voorberg, Angelique
    Kamsteeg, Marijke
    Haeck, Inge
    De Graaf, Marlies
    Thijs, Judith
    De Boer, Joke
    De Bruin-Weller, Marjolein
    ACTA DERMATO-VENEREOLOGICA, 2022, 102
  • [9] Evaluation of risk factors for dupilumab-associated ocular sequelae in the treatment of atopic dermatitis
    Reddy, Varsha
    Lum, Alexa
    Kitsios, Katerina
    Shil, Swarna
    Nattis, Alanna
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [10] Management of dupilumab-associated conjunctivitis in atopic dermatitis
    Aszodi, Nora
    Thurau, Stephan
    Seegraeber, Marlene
    de Bruin-Weller, Marjolein
    Wollenberg, Andreas
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 (05): : 488 - 492
12345